Skip to content

Application Value of Contrast-enhanced Ultrasound in Core Needle Biopsy of Breast Cancer

Application Value of Contrast-enhanced Ultrasound in Core Needle Biopsy of Breast Cancer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400089906
Enrollment
Unknown
Registered
2024-09-19
Start date
2023-08-01
Completion date
Unknown
Last updated
2024-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

Standard Group:Using conventional ultrasound before core needle biopsy in the standard group
CEUS Group:Using CEUS before core needle biopsy in the CEUS group

Sponsors

Baoding NO.1 Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Patients over 18 years old; 2. Patients with breast space occupying lesions shown on ultrasound and clinically assessed to require core needle biopsy; 3.Patients willing to undergo surgical resection after biopsy; 4.Patients with informed consent.

Exclusion criteria

Exclusion criteria: 1. Previous history of puncture biopsy in other hospitals; 2. Previous treatment history of radiotherapy and chemotherapy, targeted drug therapy, etc.; 3. Patients with contraindications of puncture, surgery or CEUS; 4. Patients who plan to undergo radiotherapy, chemotherapy and targeted therapy after puncture; 5. Patients who refuse to undergo surgery after biopsy; 6. Patients who disagree.

Design outcomes

Primary

MeasureTime frame
Pathological classification;Estrogen receptor;Progesterone receptor;Human epidermalgrowth factor receptor-2;Ki-67;

Countries

China

Contacts

Public ContactXin Liu

Baoding NO.1 Central Hospital

lxlx3369@126.com+86 186 1778 9252

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026